These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11717174)

  • 21. Validated assays for human cytochrome P450 activities.
    Walsky RL; Obach RS
    Drug Metab Dispos; 2004 Jun; 32(6):647-60. PubMed ID: 15155557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of glyburide on human cytochrome p450 isoforms in human liver microsomes.
    Kim KA; Park JY
    Drug Metab Dispos; 2003 Sep; 31(9):1090-2. PubMed ID: 12920163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
    Daniel WA; Kot M; Wójcikowski J
    Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of cytostatically active 6-aminobenzo[c]phenanthridines on cytochrome P450 enzymes in human hepatic microsomes.
    Zebothsen I; Kunze T; Clement B
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):37-43. PubMed ID: 16867169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of flavonoids isolated from Scutellariae radix on cytochrome P-450 activities in human liver microsomes.
    Kim JY; Lee S; Kim DH; Kim BR; Park R; Lee BM
    J Toxicol Environ Health A; 2002 Mar; 65(5-6):373-81. PubMed ID: 11936218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450.
    Ueng YF; Don MJ; Jan WC; Wang SY; Ho LK; Chen CF
    Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the main human cytochrome P450 enzymes involved in safrole 1'-hydroxylation.
    Ueng YF; Hsieh CH; Don MJ; Chi CW; Ho LK
    Chem Res Toxicol; 2004 Aug; 17(8):1151-6. PubMed ID: 15310247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolite-P450 complex formation by methylenedioxyphenyl HIV protease inhibitors in rat and human liver microsomes.
    Chiba M; Nishime JA; Chen IW; Vastag KJ; Sahly YS; Kim BM; Dorsey BD; Vacca JP; Lin JH
    Biochem Pharmacol; 1998 Jul; 56(2):223-30. PubMed ID: 9698076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse.
    Chauret N; Gauthier A; Martin J; Nicoll-Griffith DA
    Drug Metab Dispos; 1997 Oct; 25(10):1130-6. PubMed ID: 9321515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent.
    Nicolas JM; Collart P; Gerin B; Mather G; Trager W; Levy R; Roba J
    Drug Metab Dispos; 1999 Feb; 27(2):250-4. PubMed ID: 9929511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of cytochrome P450 activities by 7,8-benzoflavone and its metabolites.
    Lee HS; Jin C; Park J; Kim DH
    Biochem Mol Biol Int; 1994 Oct; 34(3):483-91. PubMed ID: 7833826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes.
    Easterbrook J; Lu C; Sakai Y; Li AP
    Drug Metab Dispos; 2001 Feb; 29(2):141-4. PubMed ID: 11159803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of selective cytochrome P-450 inhibitors on the metabolism of thioridazine. In vitro studies.
    Daniel WA; Syrek M; Haduch A
    Pol J Pharmacol; 1999; 51(5):435-42. PubMed ID: 10817545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dihydralazine-induced inactivation of cytochrome P450 enzymes in rat liver microsomes.
    Masubuchi Y; Horie T
    Drug Metab Dispos; 1998 Apr; 26(4):338-42. PubMed ID: 9531521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictions of cytochrome P450-mediated drug-drug interactions using cryopreserved human hepatocytes: comparison of plasma and protein-free media incubation conditions.
    Mao J; Mohutsky MA; Harrelson JP; Wrighton SA; Hall SD
    Drug Metab Dispos; 2012 Apr; 40(4):706-16. PubMed ID: 22228749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly selective inhibition of human CYP3Aa in vitro by azamulin and evidence that inhibition is irreversible.
    Stresser DM; Broudy MI; Ho T; Cargill CE; Blanchard AP; Sharma R; Dandeneau AA; Goodwin JJ; Turner SD; Erve JC; Patten CJ; Dehal SS; Crespi CL
    Drug Metab Dispos; 2004 Jan; 32(1):105-12. PubMed ID: 14709627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of potent CYP3A4 inhibitors in Schisandra fruit extract.
    Iwata H; Tezuka Y; Kadota S; Hiratsuka A; Watabe T
    Drug Metab Dispos; 2004 Dec; 32(12):1351-8. PubMed ID: 15342469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cumene hydroperoxide-supported demethylation reactions catalyzed by cytochrome P450 2B4 lacking the NH2-terminal sequence.
    Zhang Y; Pernecky SJ
    Biochem Biophys Res Commun; 1999 Apr; 258(1):32-8. PubMed ID: 10222230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes.
    Liu Y; Zhang JW; Li W; Ma H; Sun J; Deng MC; Yang L
    Toxicol Sci; 2006 Jun; 91(2):356-64. PubMed ID: 16547074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variables in human liver microsome preparation: impact on the kinetics of l-alpha-acetylmethadol (LAAM) n-demethylation and dextromethorphan O-demethylation.
    Nelson AC; Huang W; Moody DE
    Drug Metab Dispos; 2001 Mar; 29(3):319-25. PubMed ID: 11181502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.